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Abstract
The analysis of behavior requires that the underlying neuronal circuits are identified and genetically isolated. In several
major model species—most notably Drosophila—neurogeneticists identify and isolate neural circuits with a binary
heterologous expression-control system: Gal4–UASG. One limitation of Gal4–UASG is that expression patterns
are often too broad to map circuits precisely. To help refine the range of Gal4 lines, we developed an intersectional
genetic AND operator. Interoperable with Gal4, the new system’s key component is a fusion protein in which the
DNA-binding domain of Gal4 has been replaced with a zinc finger domain with a different DNA-binding specificity.
In combination with its cognate binding site (UASZ) the zinc-finger-replaced Gal4 (‘Zal1’) was functional as a standalone
transcription factor. Zal1 transgenes also refined Gal4 expression ranges when combined with UASGZ, a hybrid upstream
activation sequence. In this way, combining Gal4 and Zal1 drivers captured restricted cell sets compared with single
drivers and improved genetic fidelity. This intersectional genetic AND operation presumably derives from the
action of a heterodimeric transcription factor: Gal4-Zal1. Configurations of Zal1–UASZ and Zal1-Gal4-UASGZ are
versatile tools for defining, refining, and manipulating targeted neural expression patterns with precision.
Introduction
For the analysis of neural circuits and behavior, neuro-
scientists use transgenic techniques to isolate neuronal
groups with precision. Neurogeneticists working with
the vinegar fly Drosophila melanogaster have developed
a sophisticated, versatile toolkit that includes a founda-
tional transcriptional system for mapping and manipu-
lating neural circuits: Gal4–UASG [5]. This system
typically uses two fusion transgenes: endogenous fly enhan-
cer sequences are placed upstream of the yeast transcrip-
tion factor Gal4; effector transgenes are fused to Gal4’s
upstream activation sequence (UASG). This arrangement
places the effector under the in trans transcriptional control
of the enhancer [5]. The Gal4–UASG method has been
used for cell-specific genetic rescue, gene overexpression,
reporter expression, RNA-interference screens, optogenetic
physiology, and many other applications [3, 18]. While this
tool is vitally useful, one challenge to dissecting neuron–be-
havior relationships has been that Gal4-linked enhancers
often capture more cells than are functionally relevant. To
improve the precision of transgene expression, neural cir-
cuit analysis uses a variety of molecular strategies to produc
AND and NOT genetic logic, producing expression
refinements by intersection. Intersectional methods use ei-
ther a repressor of Gal4, a targeted recombinase system, a
leucine-zipped split-Gal4, or a combination. The native
Gal4 repressor, Gal80, is used as a genetic NOT operator to
exclude expression from a subset of cells captured by a
driver [25]. The flippase (Flp) recombinase specifically ex-
cises genomic sequences flanked by flippase recognition
target (FRT) sites. In the Flp-out method, Flp is transiently
expressed under the control of a heat shock promoter to
both generate AND and NOT operations [26]. Stochastic
single-cell specificity can be achieved with the ‘mosaic ana-
lysis with repressible cell marker’ (MARCM) technique
[16]. Flp-FRT is also used in the ‘Flippase-induced
intersectional Gal80/Gal4 repression’ (FINGR) inter-
sectional method [4], wherein stable, elevated levels
of Flp are expressed from an enhancer to add or re-
move Gal80 expression from a subset of Gal4 driver
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cells with some stochasticity [24]. The split-Gal4 method
uses a bipartite Gal4 variant, in which a heterodimeriza-
tion leucine zipper joins the DNA-binding and activation
domains; it is active as a transcription factor when both
components are expressed in the same cell, producing
AND logic between the two half-drivers [17]. A non-inter-
sectional approach to improving cell set specificity uses
driver lines constructed with small enhancer fragments in-
stead of large upstream regions [12, 13, 21]. Such genomic
fragments contain fewer enhancer modules, so they tend
to express in more restricted anatomical ranges: an esti-
mated 4- to 10-fold greater specificity compared with en-
hancer traps [21].
In light of the extensive Gal4 resources currently avail-
able, we aimed to develop an tool that would refine
existing Gal4 lines. The DNA-binding domain of Gal4 is
a zinc finger that can be substituted with another do-
main, conferring novel DNA-binding affinity in vitro
[22]. We implemented and tested a zinc finger variant of
Gal4 that works both as a standalone binary transcrip-
tion system and as a genetic AND operator in combin-
ation with existing Gal4 lines. Using several enhancer
sequences associated with particular neurotransmitter
systems, we demonstrated that the variant transcription
factor -termed Zinc finger-replaced Gal4 (Zal1) can
drive expression from a corresponding upstream activat-
ing sequence, termed UASZ. When co-expressed in the
same cells, Gal4 and Zal1 were active in the presence of
a hybrid upstream activation sequence that contained
asymmetric binding sites (UASGZ) for the Gal4-Zal1
heterodimer. This method allowed targeting of expres-
sion to neurons in which both transcription factor types
are expressed. The Zal1-Gal4-UASGZ system will enable
the refinement of existing Gal4 lines to isolate precise
neuronal types.
Results
Ternary UAS expression system design
Gal4 binds to its cognate upstream activating DNA
motif, referred to here as UASG (Fig. 1a). Gal4 can be
used to drive specific expression of a responder transgene
(e.g. green fluorescent protein, GFP) in defined cell types
such as specific Drosophila neurons (Fig. 1b). Pomerantz
and colleagues previously designed a transcription-factor
fragment that fused the first two zinc fingers of mouse
transcription activator EGR1 (previously referred to as
ZIF268) with the linker and dimerization domains of Gal4
[22]. In an in vitro study, they showed that the resulting
truncated fusion protein, zinc finger Gal4 dimerization 1
(ZFGD1), bound to DNA containing its corresponding
UAS (here termed UASZ), a palindromic site with
inverted EGR1 finger-binding sites (Fig. 1c). Using the
same fusion design as ZFGD1, we generated a gene encod-
ing a full-length transcription factor, zinc finger-replaced
Gal4 (Zal1), to be used in vivo to activate genes placed
downstream of a UASZ tandem repeat (Fig. 1d). Since het-
erodimeric ZFGD1 proteins assemble in vitro and specific-
ally bind to hybrid UAS sites in DNA [22], we anticipated
that a full-length heterodimeric Gal4/Zal1 transcription fac-
tor would form in vivo, bind hybrid sites in the genome
(Fig. 1e), and activate a UASGZ-controlled responder in
cells where Gal4 and Zal1 are co-expressed (Fig. 1f).
VGlut-Zal1 drives broad UASZ-GFP expression
The vesicular glutamate transporter (VGlut) enhancer
was previously used to make a VGlut-Gal4 enhancer-fu-
sion construct; it captures a large—though non-compre-
hensive— set of glutamatergic cells [10]. Following a
similar method, transgenic flies were prepared to carry
Zal1 fused to the same VGlut enhancer region [10]. Pro-
geny of VGlut-Zal1 crossed with UASZ-GFP expressed
GFP throughout the brain (Fig. 2a–b). The VGlut-Zal1
pattern differed from that of VGlut-Gal4 (Fig. 2c–d).
These differences could arise from the expression vari-
ation that can arise from genomic insertion sites [19],
driver vector design, and possible differences in activity
between the two transcription factors. These results
demonstrate that Zal1 is functional in the Drosophila
brain, albeit with different expression from
VGlut-Gal4.
Co-expressed Zal1 and Gal4 drive expression from a
hybrid UAS
To explore the utility of Zal1 for expression refinement,
we made flies carrying VGlut-Gal4, VGlut-Zal1, and a
responder transgene UASGZ-GFP. We hypothesized that
a heterodimer of the two transcription factors would
drive expression of GFP through the UASGZ hybrid
binding sequence. Flies carrying all three transgenes
showed GFP expression in many cells, indicating that
the Gal4-Zal1 heterodimer did form in vivo and was
functional at the UASGZ sites (Fig. 2e–f ). There were
qualitative differences between GFP expression in the
Zal1-Gal4-UASGZ heterodimer brains and the respect-
ive monomer-expressing brains, possibly arising from
differences in transgene design. Thesedata verify that
Zal1 and Gal4 canactivate transcription from a hybrid
UASGZ, and thus have the potential to drive expression
at an intersection.
VGlut homodimeric lines do not activate non-cognate
UAS sites
The specificity of intersectional expression patterns from
Zal1-Gal4 combinations is predicated on the specificity
of binding to their respective UAS sites: broad cross-re-
activity would make an OR operation instead. Possible
cross-reactivity was examined in non-cognate UAS/tran-
scription factor controls. A VGlut-Gal4 line were crossed
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with a UASZ-CD8::GFP(‘UASZ-GFP’) reporter line. Con-
focal images revealed almost no GFP expression in the
brain, indicating that VGlut-Gal4 by itself does not drive
expression from a UASZ responder (Fig. 2g). Similarly, a
VGlut-Zal1 line was evaluated by crossing it with
UASG-GFP; brain expression in the progeny of these
crosses was weak (Fig. 2h), indicating that cross-reactivity
is minimal. As previously reported for theirin vitro coun-
terparts [22], the present results show that in vivo Zal1
and Gal4 interact with their cognate UAS sites specifically.
To exclude the possibility that homodimeric factors were
inappropriately active at the hybrid UASGZ sites, VGlut-
Gal4 flies were crossed with UASGZ-GFP. Green fluores-
cence was low (Fig. 2i), indicating that Gal4 activation
from tandem UASGZ sites is poor. Similarly, we examined
whether VGlut-Zal1 alone drove robust expression from
UASGZ-GFP (Fig. 2j): it did not.
VGlut-Zal1 restricts the expression breadth of Gal4 lines
The VGlut-Gal4-dependent activity of VGlut-Zal1 at
UASGZ suggested that VGlut-Zal1 could be useful to
restrict the cellular range of existing Gal4 transgenes. To
test this idea, we examined enhancer trap lines with and
without VGlut-Zal1. The Orco-Gal4 line drives expres-
sion in a majority of olfactory receptor neurons [15],
sending axonal projections to the antennal lobe (Fig. 2k).
When Orco-Gal4 was combined with VGlut-Zal1 and
UASGZ-GFP, green fluorescence was absent (Fig. 2l).
This result likely reflects that VGlut-Zal1 and the cho-
linergic olfactory-receptor neurons have no overlap.
Another line, OK107, drives expression in the mush-
room body, the pars intercerebralis and the antennal
lobe (Fig. 2m). When this line was crossed with gluta-
matergic Zal1, the mushroom body and pars intercer-
ebralis were absent: only some antennal-lobe cells and
a few dorsal cells remained (Fig. 2n). The same type
of experiment was performed on 16 Gal4 enhancer-
trap lines [11]. Compared with these lines’ own gen-
erally broad expression ranges, the distributions in
combination with Vglut-Zal1 were sharply more lim-
ited (Additional file 1: Figure S1A–P). Several of the
intersectional brains displayed almost no GFP+ cells
(NP6235, NP2002), suggesting that Zal1-Gal4 does
not produce broadly mistargeted or ectopic responder
expression (Additional file 1: Figure S1K’ & Q’).
Gal4-Zal1 activation is susceptible to Gal80 repression
We aimed to determine whether the Gal4-Zal1 dimer was
repressible by Gal80. The NP4683 enhancer trap line ex-
presses in several areas, including the antennal lobe,
mushroom body, the ellipsoid body, subesophageal zone
(SEZ) and the ventral nerve cord (VNC) (Additional file 2:
Figure S2A). As with other lines,VGlut-ZAL1 intersection
produced a reduced expression range; it excluded the
mushroom body and antennal lobe expression, but
retained GFP in the ellipsoid body, SEZ and VNC
(Additional file 2: Figure S2B). The tsh-GAL80 driver re-
presses GAL4 expression in the thoracic and abdominal
nervous system [8]. In flies carrying both the ternary system
and tsh-GAL80 (tsh-Gal80/UASGZ-GFP; VGlut-ZAL1/
NP4683), the ellipsoid body remained brightly GFP+, but
the SEZ and VNC expression was diminished (Additional
file 2: Figure S2C). These data are compatible with the idea
that the Gal4-Zal1 dimer is repressible by Gal80.
Fig. 1 Structural models of Gal4 and Zal1; the experimental expression concept. a Structural model of Gal4 protein domains in the native homodimeric
configuration; two zinc fingers constitute the DNA-binding domain. Only the DNA-binding domain, linker and dimerization domain of Gal4 are shown. b A
hypothetical expression pattern for Gal4 homodimer driving expression from a UASG effector gene in the adult fly brain. c. A hypothetical structural model
of Zal1 protein in which the zinc fingers of Gal4 are replaced with fingers 1 and 2 from the crystal structure of EGR1, shown in red. d A hypothetical
expression pattern for Zal1 homodimer driving expression from a UASZ effector gene. e A model of the Gal4-Zal1 heterodimer. f A hypothetical
expression pattern produced by Gal4-Zal1 heterodimer in the presence of a UASGZ effector gene
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These qualitative observations show that Zal1-UASGZ
is interoperable with both Gal4 and Gal80, and can limit
and refine the expression range of existing lines. How-
ever, the glutamatergic system is a challenging target for
quantitative analyses of expression: the cells are numer-
ous; and the transporter is predominantly present at the
nerve terminals—the α-VGLUT antibody labels cell bodies
weakly, rendering their identification and quantification
Fig. 2 VGlut-Zal1 drives reporter expression with similar fidelity to VGlut-Gal4 and generates distinct intersected expression pattern in combination
of Gal4 lines. In adult fly brains, widespread GFP expression was observed for both VGlut drivers and their combination. a–b Maximum intensity
projection images of (a) the brain anterior to the ellipsoid body and (b) the ellipsoid-posterior brain of a UASZ-mCD8GFP/+; VGlut-Zal1/+
fly stained with α-GFP (green) and α-DLG (magenta) antibodies. c–d Maximum intensity projections of the anterior (c) and posterior (d)
expression patterns in a UASG-mCD8GFP/+; VGlut-Gal4/+ brain stained with α-GFP (green) and α-DLG (magenta) antibodies. e–f Projection
images of an anterior (e) and posterior (f) portions of a UASGZ-mCD8GFP/+; VGlut-Zal1/VGlut-Gal4 brain stained with α-GFP (green) and
α-DLG (magenta) antibodies. g–h. VGlut-Gal4 and VGlut-Zal1 are not individually active at non-cognate UAS sites. VGlut-Gal4; UASZ-GFP
and VGlut-Zal1; UASG-GFP brains stained with α-GFP showed little or no green fluorescence. i.VGlut-Gal4; UASGZ-GFP and j. VGlut-Zal1; UASGZ-
GFP brains were α-GFP-negative. k. Expression pattern of Orco-Gal4 crossed with UASG-GFP. l Intersectional expression pattern of Orco-Gal4 generated
using VGlut-Zal1; no GFP expression was observed. m The expression pattern of OK107-Gal4 crossed with UASG-GFP. n The intersectional expression
pattern of OK107-Gal4 with VGlut-Zal1. Images show staining with α-GFP (green) and α-DLG (magenta). Scale bars represents 200 μm; dorsal is up
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inaccessible (data not shown). Therefore, we turned to
other neurogenetic systems to quantify Zal1 performance.
Crz-Zal1 drives expression in Corazonergic neurons
As we observed qualitative differences in GFP expression
in the intersected heterodimer brains and the respective
monomer expressing brains, We aimed to quantify Zal1
performance, for that, we used the Corazonin (Crz)
neuropeptide system. The anatomy of these cells is tract-
able: a Crz-Gal4 line is available; Crz is expressed in just
6–8 cells per hemisphere; and an α-Crz antibody can be
used for Crz+ cell identification [6]. To analyze Crz-Zal1
brain expression for comparison with Crz-Gal4, we
fused Zal1 to the Crz enhancer region [6]. Control
brains carrying the non-cognate driver–responder com-
binations displayed either GFP levels that were undetect-
able (UASZ, UASG), or weak (UASGZ, Fig. 3m–p). This
expression in Crz-Zal1 > UASGZ-GFP brains may be
due to a mild affinity of Zal1 for the 20 binding
half-sites in UASGZ-GFP. In cognate, single-driver com-
binations, both Crz-Zal1 and Crz-Gal4 drove strong ex-
pression in numerous optic-lobe cells, the ventral nerve
cord and in ~ 7 Corazonergic dorsal protocerebral neu-
rons (Fig. 3a–h). This suggested that the two driver types
similar patterns. We crossed both drivers with the
UASGZ-GFP hybrid reporter, and found that the result-
ing brains had expression patterns nearly identical to the
single-driver lines (Fig. 2i–l). Excluding broad ectopic
expression in the optic lobes, Crz-Gal4 has 67% ectopic
cells (~ 15 cells) in the non-optic-lobe brain (Fig. 3a–d,
see arrow, Fig. 4). However, this ectopic expression was
excluded when Crz-Gal4 and Crz-Zal1 were intersected
(Fig. 3 j-l, Fig. 4), indicating that while both the Zal1 and
Gal4 drivers have similar extensiveness within Crz +
cells, Crz-Zal1 has better fidelity—and establishes that a
Zal1 driver can be used to refine a Gal4 driver pattern.
These data further verify the hypothesis that Zal1 is use-
ful as an effective intersectional transactivator, and sup-
port the idea that Zal1 can be used to improve Gal4
driver fidelity.
Trh-Zal1 drives expression in serotonergic cells
We tested Zal1 in a third context: the serotonergic sys-
tem. Serotonin synthesis relies on the Tryptophan hy-
droxylase (Trh) gene; in a Gal4 fusion, the Trh enhancer
region drives expression in nearly all ~ 90 serotonergic
cells [1]. We prepared a Trh-Zal1 line and assessed expres-
sion in controls: Trh-Gal4 combined with UASZ-GFP was
inactive; Trh-Zal1 crossed with UASG-GFP had no measur-
able expression; and green fluorescence in Trh-Gal4 >
UASGZ-GFP flies was undetectable (Fig. 5m–o). Trh-Zal1 >
UASGZ-GFP single-driver brains displayed off-target ex-
pression in a few cells, presumably from homodimeric
Zal1 activation from the hybrid UASGZ sites (Fig. 5p,
see arrows).
Compared with the controls, the three cognate driver-
responder lines revealed expression patterns that were
broad and strong. Trh-Gal4 > UASG-GFP expression in-
cludes a majority of brain 5-HT+ cells (Fig. 5a–d): 36
[95CI 32.5, 39.8] cells per hemisphere across nine clus-
ters, with 85.7% fidelity and 90% extensiveness (Fig. 6a).
Expression in Trh-Zal1 > UASZ-GFP brains were 87.5%
extensive, expressing in ~ 26 serotonergic cells per hemi-
sphere (25.5 [95CI 22, 31]) across five serotonergic
clusters (Fig. 5e–h), with < 2 ectopic cells: 95.7% fidelity
(Fig. 6a). The double-driver combination Trh-Gal4 +
Trh-Zal1 > UASGZ-GFP expressed in ~ 24 cells per
hemisphere across five cell clusters (Fig. 5i–l), represent-
ing 82% extensiveness and 100% fidelity (Fig. 6a). These
results further verify Zal1’s interoperability with Gal4 for
intersectional neurogenetics.
Trh-Zal1–Gal4 combinations improve expression fidelity
While the Vglut-Zal1 experiments showed that Zal1 can
operate with enhancer-trap lines to limit expression, we
were not able to quantify the resulting fidelity. Using an
α-5-HT antibody that robustly stains fly serotonergic cell
bodies, we aimed to test whether Trh-Zal1 could be
used to refine low-fidelity serotonergic Gal4 lines. A vis-
ual scan of the FlyLight Gal4 collection [12] found pos-
sible serotonergic-driving candidate lines. Subsequent
immunostaining of these lines identified four lines ex-
pressing in some serotonergic cells (Fig. 7a–d). However,
these lines included numerous non-5-HT neurons that
were densely packed and highly abundant (especially in
the optic lobe). Such broad and ectopic expression
would confound the interpretation of behavior from
such lines; it also prevented quantification of these lines’
serotonin fidelity. Combining these drivers with Zal1-
UASGZ greatly reduced range while improving fidelity
(Fig. 7a’–d’). For example, R22H10-Gal4 drives intense
fluorescence in non-serotonergic central-complex cells
(Fig. 7a); the Trh-Zal1 AND operation on this driver ex-
cluded central-complex expression almost completely.
The double-driver combination retained expression in a
majority of verified serotonergic neurons: 75% [95CI 71,
80] (Fig. 7a’). Overall, counting cells in the four lines
found that the mean Gal4-Zal1 intersectional 5-HT+
fidelity was 77% [95CI 65, 92] (Fig. 6b). These data verify
the hypothesis that Zal1 intersection is useful to refine
Gal4 driver specificity.
Discussion
Elucidation of the anatomical and genetic complexity of
the brain will require a range of progressively sophisti-
cated tools. Here, we present a method to refine the ex-
pression range of existing Gal4 lines. At their non-cognate
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Fig. 3 A combination of Crz-Zal1 and Crz-Gal4 drives expression in corazonergic cells. Maximum intensity projection (MIP) images of brain
immunofluorescence. a–d MIP images of (A) of a UASG-mCD8GFP/+;Crz-Gal4/+ brain stained with α-GFP (green) and α-DLG (magenta) antibodies.
b An image of a Crz-Gal4/UASZ-mCD8GFP brain stained with α-GFP (green), (C) and α-Crz antibodies (magenta) and (D) combined image. e–h UASZ-
mCD8GFP/+; Crz-Zal1/+ brains stained with α-GFP, (e) α-DLG (magenta) and (h) α-Crz. i UASGZ-mCD8GFP/+;Crz-Gal4/+; Crz-ZAL1 brains stained
with α-GFP and α-DLG (magenta) antibodies. j A Crz-Gal4/UASGZ-mCD8GFP brain stained with α-GFP, k α-Crz, and l combined image. m. Control
brains were stained with α-GFP and α-Crz. Crz-Gal4 is inactive at non-cognate UASZ sites in Crz-Gal4; UASZ-GFP brains. n Crz-Zal1; UASG-GFP
brains stained with α-GFP showed no green fluorescence. o Crz-Gal4; UASGZ-GFP brains showed no fluorescence. p Crz-Zal1; UASGZ-GFP showed weak
expression in a few Crz cells (arrows indicate expression). Scale bar represents 200 μm; dorsal is up
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UAS sites, Gal4 or Zal1 alone have activity that is either
weak or absent. Gal4-Zal1 heterodimers are functional at
a hybrid UASGZ site in vivo. Zal1 intersection restricts
the number of cells being captured; as judged by antibody
counterstaining, Zal1 intersection produces expression
with high fidelity.
The system has several limitations. First, Zal1 has
weak off-target activity at a 20 × UASGZ responder; this
means that the combined Gal4-Zal1 expression pattern
will include low expression some cells from the Zal1 set.
This issue necessitates that behavioral experiments in-
clude Zal1 > UASGZ control flies, to check whether an
effect arises either from the non-cognate expression or
the intersectional expression. Note that this control
would be in addition to the use of conventional re-
sponder controls. Second, as Gal4-Zal1 is incompatible
with existing UASG responder lines, new responder lines
for the range of neural inhibitors, activators and other
effectors currently will need to be developed. Such ef-
forts, while considerable, will not require the generation
of a large collection, will require only a handful of key
effectors for most applications, and will augment the
utility of the many existing Gal4 lines.
Other transactivator expression systems have been im-
plemented in Drosophila, including LexA-lexAop [14, 27]
and Q [23]. Such systems can be used with Gal4-UASin a
number of configurations, including driving expression in
two distinct cell sets to study their interaction. Our data
indicate that Zal1-UASZ system can be used this way—in
conjunction with Gal4—with a possible benefit of both
systems remaining susceptible to Gal80-mediated NOT
operations, comparable to intended use of the LexA::GAD
fusion protein [27].
The utility of Zal1 can be placed in context with exist-
ing Gal4 AND operators. Zal1 is comparable to
split-Gal4, though has the added capability of enabling
AND operations on the many existing Gal4 lines, a valuable
practical benefit. Enhancer trap-driven Flp recombinase
can restrict Gal4 expression, though weakly-expressing Flp
lines may be affected by stochastic recombination [24].
Currently, Gal4 resources include the Kyoto Stock Center’s
~ 4300 lines, and the Bloomington Drosophila Stock
Center’s > 7000 lines. Many Gal4 drivers capture cellu-
lar sets that do not map cleanly to physiological or
behavioral function. The ability to restrict expression
range with Zal1-UASGZ will further extend the utility
of these existing collections.
In conclusion, this new expression system provides
a versatile tool for the examination of neuronal func-
tion, most importantly, for the refinement of Gal4
drivers. Zal1 promises to be a useful method for mapping
neural circuits.
Methods
Replacement of the zinc finger in Gal4 with EGR1 domains
A Gal4 derivative was generated by fusing DNA se-
quences corresponding to the first two zinc fingers of the
mouse transcription activator EGR1 (previously called
ZIF268) with DNA coding for residues 41–881 of
Gal4, a sequence that includes Gal4’s linker and
dimerization domains, as well as the transcriptional-
activation regions (Fig. 1a–c). Codon-optimized DNA
coding for residues 2–59 of EGR1 were synthesized
(Genscript Ltd) with an upstream DNA linker that in-
cluded a KpnI restriction site and 210 base pairs of
Gal4 sequence that included an RsrII site. This sec-
tion was digested and ligated into the pBPGA-
L4.2Uw-2 vector [20], replacing the first 40 residues
of Gal4 while leaving the domains necessary for
dimerization and activation intact; this construct was
labeled pSVRZal.
Construction of VGlut-, Trh-, and Crz-Zal1 driver lines
To generate drivers that would express Zal1 in gluta-
matergic cells, serotoninergic, and corazonin (Crz)
positive cells, the VGlut, Trh, and Crz enhancer re-
gions were subcloned upstream of Zal1 to generate
Fig. 4 Quantification of Gal4- and Zal1-mediated genetic intersection
in Crz cells. A Venn plot shows cell counts of α-GFP and α-Crz antibody
staining as percentages. Bar heights are quantitative; bar areas are not.
Counts of cells staining positively for Crz were defined as constituting
100% of α-Crz + cells (magenta bar). Counts of cells staining α-GFP+
were defined as the driver’s expression range (green bar). The overlap
between α-Crz + and α-GFP+ cells is displayed in white. Left The
Crz-Gal4 driver expresses GFP in all seven Crz + neurons, along
with expression in 15 ectopic cells. Center Crz-Zal1 expresses in
all 7 corazonergic cells along with ectopic expression in less than one
cell. Right The Crz-Gal4/Crz-Zal1 double driver expresses in
Crz + cells exclusively
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VGlut-Zal1, Trh-Zal1 and Crz-Zal1 lines respectively.
In the case of VGlut-Zal1, a 5.5-kb piece of DNA
[10] immediately upstream of the Vglut translation
start site was used. For generating Trh-Zal1 and
Crz-Zal1 lines, the same enhancer fragments which
have been used to prepare Trh-Gal4 [1] and Crz-Gal4
[6] were amplified using PCR and subcloned into
pSVRZal. For Trh-Zal1, the 1.6 kb promoter region
[1] immediately upstream of the Trh transcriptional
start site was used. For Crz-Zal1, a 434 bp promoter
region [6] upstream of the putative Crz transcription
start site was used. All lines were inserted into the
attP2 sites on the 3rd chromosome (BestGene, Inc) of
w1118flies.
Fig. 5 The Trh-Zal1 + Trh-Gal4 combination drives expression in the majority of serotonergic cells a–d. MIPs of (a) of a UASG-mCD8GFP/+; Trh-Gal4/+
brain stained with α-GFP (green) and α-DLG (magenta) antibodies. b A Trh-Gal4/UASG-mCD8GFP brain stained with α-GFP (green), (c) with α-5HT
antibodies and (d) combined image. e-h. MIPs of (e) a UASZ-mCD8GFP/+; Trh-Zal1/+ brain stained with α-GFP and α-DLG (magenta); (f) a
Trh-Zal1/UASZ-mCD8GFP brain stained with α-GFP (green), (g) with α-5HT, and (h) combined image. i–l. MIPs of (i) a UASGZ-mCD8GFP/+;
Trh-Zal1/Trh-Gal4 brain stained with α-GFP and α-DLG (magenta); (j) a Trh-Zal1; Trh-Gal4/UASGZ-mCD8GFP brain stained with α-GFP, (k)
with α-5HT and (l) combined image. m A Trh-Gal4; UASZ-GFP brain stained with α-GFP showed no green fluorescence n. ATrh-Zal1; UASG-GFP
brain showed no α-GFP fluorescence. o A Trh-Gal4; UASGZ-GFP brain showed no α-GFP fluorescence p. A Trh-Zal1; UASGZ-GFP brain showed weak GFP
expression in a few cells; arrows indicate expression. The brains M–P were stained with α-GFP and α-5-HT. Scale bar represents 200 μm; dorsal is up
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Construction of UASZ and UASGZ responders
The recognition site of ZFGD1 is a 25-base-pair sequence
comprising two inverted six-base-pair EGR1 partial bind-
ing sites separated by spacer DNA sequence [22]. Follow-
ing the convention set by ‘UASG’, we refer to this
palindromic site (AAGCTT-[CGCCCAGAGGACAGTCC
TATGGGCGAG × 4]-GACGTC) as ‘UASZ’. Four UASZ
sites were introduced using HindIII and AatII sites into
the vector pJFRC7-20XUAS-IVS-mCD8::GFP, replacing
the original UASG sequences [20] to produce pSVR-
4XUASZ-IVS-mCD8::GFP. Four tandem sites were used,
as longer repeats of UASZ proved intractable to synthesis
subcloning. A non-palindromic, hybrid binding site that
combined the recognition half-sites of Gal4 and Zal1 was
also synthesized, termed UASGZ (AAGCTT-[CCGG
AGTACTGTCCTATGGGCGAG × 20]-GACGTC). To
make a GFP responder construct, the UASGZ sites were
introduced into the pJFRC7-20XUAS-IVS-mCD8::GFP
vector, replacing the original UASG sites using HindIII
and AatII sites to generate pSVR-20XUASGZ-IVS-
mCD8::GFP. Earlier attempts with 5× UASGZ Vglut-Zal1
construct produced only weak expression (data not
shown). Here synthesis of 20× of tandem sites was suc-
cessful, an arrangement suitable to maximize expression
via the Gal4-Zal1 heterodimer. Both transgenes were tar-
geted to the attP40 sites on the 2nd chromosome.
Fly stocks and transgenesis
Drosophila melanogaster flies were grown on standard
medium at 23 °C–25 °C. Transgenic animals were gener-
ated with the PhiC31-mediated protocol (Bestgene Inc).
For brevity, flies transformed with pJFRC7-20XUAS-IVS-
mCD8::GFP are referred to as ‘UASG-GFP’; flies with
pSVR-4XUASZ-IVS-mCD8::GFP are referred to as
‘UASZ-GFP’; and flies with pSVR-20XUASGZ-IVS-
mCD8::GFP are referred to as ‘UASGZ-GFP’. The VGlut-
Gal4 line was a gift from Aaron DiAntonio. Trh-Gal4
(BL#38389) was procured from the Bloomington stock
center. Crz-Gal4 was a gift from Jae H. Park (The
University of Tennessee). The Gal4 lines from the Janelia
collection were obtained from Bloomington; NP enhancer
trap lines were obtained from the Kyoto Stock Center of
the Drosophila Genetic Resource Center.
Immunohistochemistry
Brains were dissected from anesthetized female flies 3–
5 days after eclosure and fixed in 4% paraformaldehyde
for 30 min at room temperature. Brains were washed for
45–60 min in PBT (phosphate buffered saline with 1%
Triton X-100 at pH 7.2). For antibody staining, the sam-
ples were further incubated in PBT containing 2% nor-
mal goat serum (sc-2043, Santa Cruz Biotechnology)
and primary antibodies overnight at 4 °C. Primary anti-
bodies were removed by several washing steps (5 ×
20 min in PBT) and secondary antibodies were added
prior to a second overnight incubation at 4 °C). Secondary
antibodies were removed with washing in PBT (5 ×
20 min) and then finally in PBS (5 × 20 min). Stained
brains were mounted in Vectashield (Vector Laboratories,
Burlingame, CA, USA) and recorded with confocal
microscopy. The following primary and secondary anti-
bodies were used: Alexa Fluor 488 rabbit α-GFP-IgG
(A-21311, Molecular Probes, 1:200 dilution), chicken
α-GFP (ab13970), rat α-mCD8 (MCD0800, Caltag
Laboratories, Chatujak, Bangkok, Thailand), rat α-5-HT
(MAB352, Merck), mouseα-DLG1 (4F3 α-DISCS LARGE
Fig. 6 Genetic intersection of Trh-Zal1 with Trh-Gal4 and enhancer trap lines results in high-fidelity expression. a. A Venn plot displays α-GFP+
expression as a percentage of α-5-HT+ cells. Left Trh-Gal4 drives expression in 90% of serotonergic neurons, along with 17% of expression
in ectopic cells; Center similarly, Trh-Zal1 drives expression in ~ 88% of serotonergic cells with ectopic expression in 4% of 5-HT+ cells. Right The
Trh-Gal4/Trh-Zal1 combination drives expression in ~ 82% of serotonergic cells with no expression in ectopic cells. The total-count mean of 5-HT+ cells
ranged from 30 to 34 per brain hemisphere. b. The R22H10-Gal4+ Trh-Zal1 combination has 51% extensiveness within the antibody stain, with 75%
fidelity. The R53C03-Gal4+ Trh-Zal1 combination: 59% extensiveness and 71% fidelity. R70A11-Gal4 + Trh-Zal1 combination: 49.5% extensiveness and
91% fidelity. R89A09-Gal4 + Trh-Zal1 combination: 47.5% extensiveness and 69.5% fidelity. The total-count mean of 5-HT+ cells ranged from 35 to 42
per brain hemisphere
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1, Developmental Studies Hybridoma Bank, 1:200 dilution),
goat α-rat Alexa Fluor 488 (A-11006, Molecular Probes,
1:200 dilution), goat α-mouse Alexa Fluor 568 (A-11004,
Molecular Probes, 1:200 dilution), rabbit α-VGLUT (Aaron
Diantonio, Washington University, 1:5000 dilution). Rabbit
α-Crz (1:500 dilution, Prof. Jan Adrianus Veenstra,
University of Bordeaux,France).
Neuroanatomical comparison of cell sets in NP and GMR
lines
With either UASG-GFP or in combination with VGlut-
Zal1; UASGZ-GFP, the following enhancer-trap lines
were subjected to α-GFP and α-DLG staining: Orco-Gal4,
OK107, NP0517, NP0588, NP3363, NP2002, NP2417,
NP3008, NP4683, NP6235, NP6330, NP0318, NP2351,
NP3156, NP0527, NP0615, NP0741, NP2252, NP0563,
NP3055, and NP0564. With either UASG-GFP—or in com-
bination with Trh-Zal1; UASGZ-GFP—the following GMR
module-trap lines were subjected to α-GFP and α-5-HT
staining: R89A09, R70A11, R53C03, and R22H01-Gal4.
Microscopy
Serial optical sections were taken in 0.5 μm steps at
1024 × 1024 pixel resolution using a confocal laser scanning
Fig. 7 In combination with different Gal4 lines, Trh-Zal1 defines distinct intersectional high-fidelity serotonergic neuronal sets. a-d. Expression
patterns of UASG-GFP signal as driven from Gal4 lines: R22H10, R53C03, R70A11, and R89A09. Brain images show staining with α-GFP (green) and
α-5HT (magenta) antibodies. a’-d’ The respective intersectional expression patterns when the drivers are used in combination with Trh-Zal1. a’
Intersectional expression from R22H10-Gal4+ Trh-Zal1 shows highly specific expression in serotonergic LP2 and SE3 cells (arrowhead) b’. Intersectional
expression of R53C03-Gal4 + Trh-Zal1 shows specific expression in a few LP2, IP and SE1 serotonergic cells. c’. Intersectional expression of R70A11-Gal4
+ Trh-Zal1 shows very specific serotonergic expression: two LP2, two PLP and IP cells. A few ectopic cells can also be seen in the subesophageal zone
(SEZ). d’ Intersection of R89A09-Gal4 with Trh-Zal1 resulted in very specific expression pattern in the serotonergic SE3 cells
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microscope (Olympus Fluoview FV1000). Imaging settings
for Fig. 2 were varied: 28–48% laser power at 488 nm, 39–
79% power at 543 nm, 440–744 PMT gain at 488 nm, and
592–794 at 543 nm. Settings for Additional file 1: Figure S1
were varied: 20–36% laser power at 488 nm, 29–51% power
at 543 nm, 394–614 PMT gain at 488 nm, and 521–708 at
543 nm. Details are provided in a spreadsheet at the
Zenodo repository. Settings for Fig. 3 were held constant:
5% laser power, 450 PMT gain for the 488 nm laser, and
361 for 555 nm. Settings for Figs. 5–7 were held constant:
5% laser power, 537 PMT gain for the 488 nm laser, and
558 for 555 nm. The stacks were visualized and analyzed
with the FIJI distribution (www.fiji.sc) of ImageJ (NIH).
Cell count analysis
For cell quantification, antibody-stained brain samples
were scanned in 0.5 μm steps with 1024 × 1024 pixel
resolution and 2 μm thickness images were prepared
using FIJI to enable counting by eye for all three staining
variations - green, magenta, and co-labeled (magenta
and green) cell bodies. All cells were counted, including
weakly stained cells; images may appear discrepant from
count statistics. Background staining with α-Crz anti-
body was observed, including some bright speckles
around the same size as some cell bodies; only cell-body
shapes with a nucleus ‘hole’ were counted. Results were
reported as the mean count and its confidence intervals;
quantification sample sizes were Nbrains = 3 samples,
Nhemispheres = 6). Venn plots were generated with a cus-
tom Matlab script; the vertical axis is meaningful, the bar
area is not proportional to the cell count. We used estima-
tion statistics in all cases, reporting means and their confi-
dence intervals [2, 7, 9].
Calculation of driver extensiveness and fidelity
To quantify the quality of different drivers and their
combinations, we defined two metrics: extensiveness (E)
and fidelity (F). Extensiveness was measured as how
completely a transgenic marker (M+) covers the range of
cells identified by an antibody (Ab+) for the cognate pro-
tein of the driver’s source gene.
E = (M+ ∩Ab+ cells/all Ab+ cells) * 100
Fidelity was defined as the percentage of marker-posi-
tive cells that also immunostained for the cognate pro-
tein product.
F = (M+ ∩Ab+ cells/all M+ cells) * 100
Extensiveness is a desirable property for drivers that
aim at capturing a complete set of cells of one neuro-
transmitter class; however, extensiveness is undesirable
for mapping the functions of individual subsets (or indi-
vidual cells). Fidelity is an unambiguously desirable
characteristic.
Additional files
Additional file 1: Figure S1. Expression patterns of NP lines with and
without VGlut-Zal1 AND operation. Expression patterns of 16 NP drivers in
the adult brain, alone and in combination with VGlut-Zal1. All brains are
stained with α-GFP (green) and α-DLG (magenta). A–R. Expression
patterns of NP0563, NP0588, NP3008, NP6330, NP2351, NP0615, NP0741,
NP2252, NP3055, NP6235, NP0318, NP3156, NP0527, NP2417, NP0517, and
NP2002 Gal4 enhancer trap lines. A’–R’. The intersectional expression
patterns in combinations with VGlut-Zal1 are shown in the panels on
the right. Several brains lack appreciable α-GFP signal, including NP0563,
NP0588, and NP0741. White scale bar represents 200 μm. (JPG 335 kb)
Additional file 2: Figure S2. Gal80 represses expression activated by
the Gal4-Zal1 dimer. A. The enhancer trap line NP4683 expressed in a
wide range of brain cells, as indicated by α-GFP (green) immunostain.
The neuropils are stained with α-DLG (magenta). B. Intersection with
VGlut-Zal1 reduced the expression range, though left expression in several
areas including the ellipsoid body, subesophageal zone, and the ventral
nerve cord. C. Combination with tsh-Gal80 left the ellipsoid body brightly
stained, while reducing expression in the subesophageal zone, and the
ventral nerve cord. (JPG 170 kb)
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